Office of the Dean > Dean's Blog

Entrepreneurship and Innovation @ Weill Cornell

Earlier this month, I spoke at the second annual Cornell Entrepreneurship Summit on entrepreneurship and innovation at Weill Cornell.

As I discussed in my talk, we have a number of budding faculty entrepreneurs on campus. For example, Hazel Szeto's startup Stealth Peptides has a compound called Bendavia that is currently being evaluated in a phase II clinical trial for its ability to reduce damage in heart attack patients. And Sheila Nirenberg, who was just named a MacArthur Foundation "genius," has developed a prosthetic device that could potentially treat blindness and founded a company called Bionic Sight. Other faculty members have started companies as well, and more are on the drawing board.

At Weill Cornell, we also have a set of new initiatives designed to increase translational research collaborations between academia and industry, with the goal of developing leading-edge therapies and cures.

Foremost among these is the Tri-Institutional Therapeutics Discovery Initiative, an exciting and innovative alliance for basic drug discovery that involves Weill Cornell, Memorial Sloan-Kettering Cancer Center, and Rockefeller University acting as one. We are delighted to be partnering with the pharmaceutical company Takeda. Takeda is contributing 10-20 medicinal chemists who will be embedded in the Belfer Research Building and will work in intimate collaboration with our faculty to develop new drugs.

We've also established an Office of Biopharma Alliances and Research Collaborations to professionalize our interactions with industry. And with NewYork-Presbyterian, we now have a Joint Clinical Trials Office, which will help streamline the process of implementing clinical trials at our medical center.

Our goal at Weill Cornell is to be at the forefront of academic medicine and to offer our patients the newest, most effective, targeted treatments possible. And forging alliances with the biopharma industry can help us to translate laboratory discoveries to new treatments and new paradigms of patient care as quickly, efficiently, and safely as possible.

Posted October 22, 2013 1:15 PM | Permalink to this post